- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Vildagliptin
Total 190 results
-
NovartisCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencySpain, Canada, France, Germany, Australia, Costa Rica, Finland, Russian Federation, Argentina, India, Norway, Sweden
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Piemonti LorenzoItalian Diabetes FoundationCompletedDiabetes Mellitus, Type 1Italy
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Johann Wolfgang Goethe University HospitalWithdrawnSDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV InhibitorsGermany
-
Cairo UniversityUnknownMetabolic Syndrome | Kidney Insufficiency | Diabete Type 2Egypt
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
University of JordanCompletedDiabetes Mellitus, Type 2Jordan
-
ClinisionWithdrawnDiabetes Mellitus, Type 2
-
Novartis PharmaceuticalsTerminatedType 2 Diabetes MellitusMexico
-
Astellas Pharma IncCompleted
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Pusan National University HospitalCompletedType 2 DiabetesKorea, Republic of
-
University of CataniaCompletedMild Cognitive Impairment
-
Samsung Medical CenterNovartisCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chiang Mai UniversityCompletedDiabetes Mellitus, Type 2 | Ischemic Heart DiseaseThailand
-
The First Affiliated Hospital of Xiamen UniversityUnknown
-
Yaounde Central HospitalUniversity of Yaounde 1; University of BueaCompletedType 2 Diabetes MellitusCameroon
-
University Hospital, Strasbourg, FranceNovartisCompleted
-
Vanderbilt UniversityCompleted
-
Lund UniversityCompleted
-
MTI UniversityCompletedReducing the Elevated Blood Pressure for Diabetic Hypertensive PatientsEgypt
-
NovartisCompleted
-
Azienda Ospedaliero-Universitaria di ParmaCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedType 2 Diabetes MellitusThailand
-
Novartis PharmaceuticalsCompletedHypoglycemia | Type 2 DiabetesColombia
-
Rio de Janeiro State UniversityLaboratory for Clinical and Experimental Research on Vascular BiologyCompleted1- Microvascular Function | 2-oxidative Stress | 3-inflammationBrazil
-
Merck Sharp & Dohme LLCCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedType-2 Diabetes MellitusHong Kong
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United KingdomCompletedInsulin Resistance | Microvascular DiseaseUnited Kingdom
-
SatRx LLCCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Germany
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt
-
Novartis PharmaceuticalsCompletedType 2 DiabetesGermany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Germany